Who Exports Topotecan from India — 45 Suppliers Behind a $3.8M Market
India's topotecan export market is supplied by 45 active exporters who collectively shipped $3.8M across 558 shipments. INTAS PHARMACEUTICALS LIMITED leads with a 87.5% market share, followed by VENUS REMEDIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 97.2% of total export value, reflecting a concentrated market structure.
Top Topotecan Exporters from India — Ranked by Export Value
INTAS PHARMACEUTICALS LIMITED is the leading topotecan exporter from India, holding a 87.5% share of the $3.8M market across 558 shipments from 45 exporters. The top 5 suppliers — INTAS PHARMACEUTICALS LIMITED, VENUS REMEDIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, UNITED BIOTECH PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED — collectively control 97.2% of total export value, indicating a highly concentrated market. Individual shares are: INTAS PHARMACEUTICALS LIMITED (87.5%), VENUS REMEDIES LIMITED (6.0%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (3.0%), UNITED BIOTECH PRIVATE LIMITED (0.5%), R.S. SURGIPHARM PRIVATE LIMITED (0.3%).
Top Topotecan Exporters from India
Ranked by export value · 45 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4MLPHARMA DRUGS & MEDI TOPOTECAN HCL FOR IN | $3.3M | 16 | 87.5% |
| 2 | VENUS REMEDIES LIMITED TOPOTECAN FOR INJECTION 4.0 MG EACH VIALTOPOTECAN FOR INJECTION 4.0 MG TOPOTECANALPHA-MEDICAL 4MGTOPOTECAN FOR INJ.4.0 MG E.VL.C.TOPOTECA | $224.6K | 8 | 6.0% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED TOPOTECAN SUN INJ 4MG HOSPITAL PACK:1 VI | $111.1K | 1 | 3.0% |
| 4 | UNITED BIOTECH PRIVATE LIMITED | $18.9K | 2 | 0.5% |
| 5 | R.S. SURGIPHARM PRIVATE LIMITED | $10.2K | 1 | 0.3% |
| 6 | ASPIRA BIOHEALTH LLP | $10.0K | 1 | 0.3% |
| 7 | PLEASANT EXPORTS | $8.2K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Topotecan exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Intas Pharmaceuticals Limited | Warning Letter, November | Yes, April 2007 | Yes | Not verified | Received FDA warning letter in November 2023; WHO-GMP certified in April 2007. |
| Sun Pharmaceutical Industries Limited | Approved | Yes, multiple facili | Yes | Not verified | FDA-approved; multiple facilities WHO-GMP certified between 2005 and 2007. |
TransData Nexus reviewed the regulatory standing of 2 leading Topotecan exporters from India. 1 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 2 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Topotecan sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The region's robust infrastructure supports numerous API manufacturers, contributing significantly to India's pharmaceutical exports. While specific data on Topotecan API production in Hyderabad is limited, the city's extensive capabilities in API manufacturing suggest potential involvement in its production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts major companies like Intas Pharmaceuticals, which, according to TransData Nexus data from 2022 to 2026, accounted for 87.5% of Topotecan exports, valued at $3.3 million. The presence of such industry leaders underscores the region's critical role in the formulation and export of Topotecan.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a significant export gateway for pharmaceutical products. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, contributed 3.0% to Topotecan exports, amounting to $0.1 million during the 2022-2026 period. The region's strategic location and well-established export infrastructure facilitate the global distribution of pharmaceuticals, including Topotecan.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a pharmaceutical manufacturing hub, largely due to favorable tax incentives. While specific data on Topotecan production in this cluster is not readily available, the region's overall contribution to pharmaceutical manufacturing suggests potential involvement in its production and distribution.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 97.2% of Topotecan exports, diversifying the supplier base can mitigate risks associated with over-reliance on a few sources.
- Engage with Established Manufacturers: Collaborate with leading companies such as Intas Pharmaceuticals and Sun Pharmaceutical Industries Limited to ensure product quality and regulatory compliance.
- Leverage Regional Strengths: Utilize the specialized capabilities of different pharmaceutical clusters—such as API production in Hyderabad and formulation expertise in Ahmedabad-Vadodara—to optimize the supply chain.
- Monitor Export Trends: Stay informed about export patterns and destination markets to identify emerging opportunities and adjust sourcing strategies accordingly.
By strategically engaging with India's diverse pharmaceutical clusters and leading manufacturers, stakeholders can enhance the efficiency and resilience of the Topotecan supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Topotecan exporters from India
SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires remaining stake in Taro Pharmaceuticals
Sun Pharma entered into a definitive merger agreement to acquire all outstanding shares of Taro Pharmaceuticals for $347.73 million. - IMPACT: This acquisition is expected to enhance Sun Pharma's specialty product portfolio, potentially influencing its Topotecan export capabilities.
Impact: This acquisition is expected to enhance Sun Pharma's specialty product portfolio, potentially influencing its Topotecan export capabilities.
Common Questions — Topotecan Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which topotecan supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, INTAS PHARMACEUTICALS LIMITED leads with 414 recorded shipments worth $3.3M. VENUS REMEDIES LIMITED (30 shipments) and SUN PHARMACEUTICAL INDUSTRIES LIMITED (4 shipments) are also established high-volume exporters.
Q How many topotecan manufacturers are there in India?
India has 45 active topotecan exporters with a combined export market of $3.8M across 558 shipments to 51 countries. The top 5 suppliers hold 97.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for topotecan from India?
Average FOB unit price: $12.87 per unit, ranging from $0.75 to $193.87. Average shipment value: $6.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 45 verified Indian exporters of Topotecan ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 558 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 51 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
558 Verified Shipments
45 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists